Medicinal Chemicals & Botanical Products · YAVNE, L3, Israel
$14.61
+0.69% (+$0.10)2026-07-17
Smart-Money SignalNeutral · 51/100— Insiders are net buyers over 90 days ($136K, 6 buys vs 0 sales)
Price Performance
Historical data including institutional events
Company Profile
O
Ofer Gonen
CEO & Executive Director
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
- Founded
- 2000
- Employees
- 121
- Headquarters
- YAVNE, L3, Israel
- Website
- www.mediwound.com
Peer ComparisonRevenue ($B)
▾Loading company sections...